Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results